More importantly, the positive correlation observed between MYBL1 and ANGPT2 expression was not only confirmed in a cohort of human HCC specimens, but also in several published datasets such as pancreatic cancer, gastric cancer, and stomach adenocarcinoma (Fig. 8D). The gene discussed is ANGPT2; the disease is hepatocellular carcinoma.